Patents by Inventor Nandan P. Koppiker

Nandan P. Koppiker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040122010
    Abstract: This invention relates to the use of cyclic guanosine 3′,5′-monophosphate phosphodiesterase type five (cGMP PDE5) inhibitors, including in particular the compound sildenafil, for the treatment of neuropathy, including in particular the treatment of diabetic neuropathy.
    Type: Application
    Filed: December 10, 2003
    Publication date: June 24, 2004
    Applicant: Pfizer Inc
    Inventors: Eric B. Grossman, Nandan P. Koppiker, Steven B. Leichter
  • Patent number: 6683080
    Abstract: Use of vardenafil or a pharmaceutical composition thereof in the preparation of a medicament for the curative, palliative or prophylactic treatment of type 2 diabetes mellitus.
    Type: Grant
    Filed: January 30, 2002
    Date of Patent: January 27, 2004
    Assignee: Pfizer Inc.
    Inventors: David A. Fryburg, Earl M. Gibbs, Nandan P. Koppiker
  • Publication number: 20030162782
    Abstract: This invention relates to the use of cyclic guanosine 3′,5′-monophosphate phosphodiesterase type five (cGMP PDE5) inhibitors, including in particular the compound sildenafil, for the treatment of neuropathy, including in particular the treatment of diabetic neuropathy.
    Type: Application
    Filed: July 26, 2002
    Publication date: August 28, 2003
    Inventors: Eric B. Grossman, Nandan P. Koppiker, Steven B. Leichter
  • Publication number: 20020143015
    Abstract: Use of vardenafil or a pharmaceutical composition thereof in the preparation of a medicament for the curative, palliative or prophylactic treatment of type 2 diabetes mellitus.
    Type: Application
    Filed: January 30, 2002
    Publication date: October 3, 2002
    Inventors: David A. Fryburg, Earl M. Gibbs, Nandan P. Koppiker